Emmanuelle Espié - Epidemiology

Author Information

Emmanuelle Espié is a researcher affiliated with the Pasteur Institute of Dakar, specifically in the Epidemiology unit located in Dakar, Senegal. Her work primarily focuses on infectious diseases, with a notable emphasis on malaria and vaccine efficacy.

Research Contributions

Emmanuelle Espié has made significant contributions to the field of epidemiology, particularly in the study of infectious diseases such as malaria and herpes zoster. Her research includes meta-analyses of individual patient data, examining the efficacy and safety of treatments, and understanding the haematological consequences of diseases. Her work is highly collaborative and often involves large data sets pooled from various sources, including the WorldWide Antimalarial Resistance Network. Espié's research has provided valuable insights into the temporal distribution of disease recrudescence, the safety profiles of vaccines, and the burden of diseases in specific populations.

Aliases

Emmanuelle Espié is also known by several aliases in academic publications, including E. Espié, Emmanuelle Espié, Emmanuelle Espie, Emmanuelle Espié, and E Espie.

Publication and Citation Metrics

Publication Year	Title	DOI
2022	Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis	10.1186/s12936-021-03980-z
2022	Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data	10.1186/s12916-022-02265-9
2020	The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data	10.1186/s12916-020-1494-3
2019	Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis	10.1186/s12936-019-2837-4
2019	The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis	10.1016/j.vaccine.2019.04.014
2019	Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors	10.1186/s12879-019-3928-0
2019	Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials	10.1016/j.vaccine.2019.03.043
2018	Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study	10.1016/j.jinf.2018.02.001
2018	The Comparative Efficacy, Safety, And Reactogenicity, of Herpes Zoster Vaccines: A Network Meta-Analysis	10.1016/J.JVAL.2018.04.1033
2018	Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000–2012	10.1136/bmjopen-2017-020528